Racotumomab-alum cancer vaccine for solid tumors in pediatric patients |
CIMAvax-EGF vaccine Predictor Phase IV |
Dose scale-up and cohort expansion with the therapeutic mAb 14F7 |
Study of the meningococcal ACW135 polysaccharide vaccine |
EFFECTIVENESS AND SAFETY IN GENERIC ABACAVIR/LAMIVUDINE AND EFAVIRENZ IN HIV NAIVE PATIENTS |
Itolizumab for Moderate-to-Severe Psoriasis-phase 3 |
Seawater-Rhinitis-Children-Phase III |
Racotumomab-alum for recurrent platimun-sensitive epithelial ovarian cancer |
SURFACEN in ARDS. Adults. Phase IV |
Itolizumab for Relapsing Remitting Multiple Sclerosis |
Safety and pharmacokinetics of CIGB-552 |
Vitamin E/ Platinum salts |
Evaluation of Biomodulin T sublingual Vs intramuscular in the elderly. |
Combifer vs NeotrofinCF-Anemia-Pregnant-Phase II |
Combifer vs Trofin phase II in anemic pregnant women. |
THERESA-5 Study |
Study in Hematological Malignancies |
CIGB-247-V vaccine in Age-Related Macular Degeneration, phase I-II randomized. |
Phase II clinical trial, controlled, randomized, double-blind to assess the immunogenicity of live attenuated vaccine candidate against cholera CV638 . |
NeuroEPO – Type 2 Spinocerebellar Ataxia Phase I-II |